Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo

British Journal of Dermatology

Volumn 165, Issue 2, 2011, Pages 285-291

  Kumar, R ^a   Parsad, D ^a   Kanwar, A J ^a   Kaul, D ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MESSENGER RNA; TRANSCRIPTION FACTOR ETS 1;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; VITILIGO; WESTERN BLOTTING; ZYMOGRAPHY;

ADULT; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELLS, CULTURED; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOCYTES; PROTO-ONCOGENE PROTEIN C-ETS-1; RNA, MESSENGER; SKIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VITILIGO; YOUNG ADULT;

EID: 79960644238     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10324.x     Document Type: Article

References (31)

1. Le Poole IC, Das PK, van den Wijngaard RM, et al. Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 1993; 2: 145-53. (Pubitemid 24009468)
2. Puri N, Mojamdar M, Ramaiah A,. In vitro growth characteristics of melanocytes obtained from adult normal and vitiligo subjects. J Invest Dermatol 1987; 88: 434-8. (Pubitemid 17053087)
3. Boissy RE, Liu Y-Y, Medrano EE, Nordlund JJ,. Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. J Invest Dermatol 1991; 97: 395-404.
4. Headley SJ, Metcalfe R, Gawkrodger DJ, et al. Vitiligo melanocytes in long-term culture show normal constitutive and cytokine-induced expression of intercellular adhesion molecule-1 and major histocompatibility complex class I and class II molecules. Br J Dermatol 1998; 139: 965-73. (Pubitemid 29010531)
5. Jimbow K, Chen H, Park JS, Thomas PD,. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 2001; 144: 55-65. (Pubitemid 32154593)
6. Kumar R, Parsad D, Kanwar AJ,. Role of apoptosis and melanocytorrhagy: a comparative study of melanocyte adhesion in stable and unstable vitiligo. Br J Dermatol 2011; 164: 187-91.
7. Lei TC, Vieira WD, Hearing VJ,. In vitro migration of melanoblasts requires matrix metalloproteinase-2: implications to vitiligo therapy by photochemotherapy. Pigment Cell Res 2002; 15: 426-32. (Pubitemid 35374624)
8. Jiang WG, Puntis MC, Hallett MB,. Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Br J Surg 1994; 81: 1576-90. (Pubitemid 24349926)
9. Trojanowska M,. Ets factors and regulation of the extracellular matrix. Oncogene 2000; 19: 6464-71. (Pubitemid 32108436)
10. Visse R, Nagase H,. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-39. (Pubitemid 36542523)
11. Nagase H, Woessner JF Jr,. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-4.
12. Woessner JF Jr,. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2l45-54.
13. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250. (Pubitemid 23103292)
14. Wu CS, Lan CCE, Wang LF, et al. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo. Br J Dermatol 2007; 156: 122-9.
15. Brew K, Dinakarpandian D, Nagase H,. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477: 267-83. (Pubitemid 30119906)
16. Borden P, Heller RA,. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 1997; 7: 159-78. (Pubitemid 27148904)
17. Jinnin M, Ihn H, Mimura Y, et al. Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets-1 and Fli1. Nucleic Acids Res 2005; 33: 3540-9. (Pubitemid 41430577)
18. Huang HC, Liu SY, Liang Y, et al. Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein. Zhonghua Yi Xue Za Zhi 2005; 85: 328-31. (Pubitemid 40253865)
19. Chakraborti S, Mandal M, Das S, et al. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003; 253: 269-85.
20. Huang CC, Papas TS, Bhat NK,. A variant form of Ets-1 induces apoptosis in human colon cancer cells. Oncogene 1997; 15: 851-6. (Pubitemid 27390138)
21. Muthusamy N, Barton K, Leiden JM,. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 1995; 377: 639-42.
22. Sharrocks AD, Brown AL, Ling Y, Yates PR,. The ETS-domain transcription factor family. Int J Biochem Cell Biol 1997; 29: 1371-87. (Pubitemid 28153488)
23. Pei H, Yordy JS, Leng Q, et al. EAPII interacts with ETS1 and modulates its transcriptional function. Oncogene 2003; 22: 2699-709. (Pubitemid 36612035)
24. Kola I, Brookes S, Green AR, et al. The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA 1993; 90: 7588-92. (Pubitemid 23249995)
25. Edmondson SR, Russo VC, McFarlane AC, et al. Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth. J Clin Endocrinol Metab 1999; 84: 1638-44. (Pubitemid 30644268)
26. Nagarajan P, Parikh N, Garrett-Sinha LA, Sinha S,. Ets-1 induces dysplastic changes when expressed in terminally differentiating squamous epidermal cells. PLoS ONE 2009; 4: e4179.
27. Bories JC, Willerford DM, Grévin D, et al. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 1995; 377: 635-8.
28. Westermarck J, Seth A, Kahari VM,. Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 1997; 14: 2651-60. (Pubitemid 27283104)
29. Reisdorff J, En-Nia A, Stefanidis I, et al. Transcription factor Ets-1 regulates gelatinase a gene expression in mesangial cells. J Am Soc Nephrol 2002; 13: 1568-78. (Pubitemid 34579246)
30. Holbrook KA,. Melanocytes in human embryonic and fetal skin: a review and new findings. Pigment Cell Res 1988; 1 (Suppl. 1): 6-17.
31. Staricco RG,. Activation of amelanotic melanocytes in the outer root sheath of the hair follicle following ultraviolet exposure. J Invest Dermatol 1962; 39: 163-4.